Pulse Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.7% | -1.6% | -0.3% | -1.3% | -2.4% | -1.4% | -3.5% | -6.2% | +1.2% | -1.5% | -0.4% | – | |
| – | +86.0% | -47.4% | +16.7% | +45.3% | +127.8% | -16.4% | -8.7% | +8.2% | -11.5% | -61.5% | +160.1% | – | |
| – | – | -214.2% | – | -25.0% | +2,003.3% | -185.3% | – | -46.9% | -1,669.8% | – | -66.4% | – | |
| – | +87.0% | -88.4% | +480.0% | +31.0% | +39.5% | -15.1% | +128.9% | -39.8% | +69.4% | -68.6% | +172.7% | – | |
| – | +87.0% | -88.4% | +480.0% | +31.0% | +39.5% | -15.1% | +173.3% | -49.6% | +69.4% | -68.6% | +172.7% | – | |
| – | – | +184.6% | – | – | – | – | – | – | -1.2% | – | – | – | |
| – | -62.6% | -62.1% | -186.9% | – | -22.1% | -69.3% | -100.0% | – | -80.6% | +480.6% | +2,255.3% | – | |
| – | – | – | – | – | -26.2% | -96.8% | -1,141.9% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.